Gelesis Holdings Inc
Change company Symbol lookup
Select an option...
GLSH Gelesis Holdings Inc
VERB Verb Technology Company Inc
FPAY FlexShopper Inc
TCS Container Store Group Inc
CMSA CMS Energy Corp
LULU Lululemon Athletica Inc
MGY Magnolia Oil & Gas Corp
LGHL Lion Group Holding Ltd
C Citigroup Inc
SYBX Synlogic Inc
Go

Gelesis Holdings, Inc. is a commercial stage biotherapeutics company built for consumer engagement. The Company focuses on advancing superabsorbent hydrogel therapeutics for chronic gastrointestinal (GI) diseases including excess weight, type two diabetes, Nonalcoholic Fatty Liver Disease (NAFLD)/ Nonalcoholic Steatohepatitis (NASH), functional constipation (FC), and inflammatory bowel disease. Its product, Plenity, is an orally administered capsule. Plenity is available by prescription via a telehealth consultation with a physician trained in weight management support, with free, unlimited follow-up visits as needed. Consumers can visit myplenity.com for online consultations. Its other pipeline candidate includes GS200 for weight loss in prediabetes and type two diabetes. It is also developing GS300 for the treatment of NAFLD and NASH, and GS500 for the treatment of Functional Constipation (FC).

Closing Price: $0.0505

Day's Change: 0.0015 (3.06%)

Bid: --

Ask: --

B/A Size: --

Day's High: 0.0505

Day's Low: 0.048

Volume (Light) Volume: 1,500 10-day average volume: 36,937: 1,500

Unable to locate that news article. Back to news results

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for varies.

Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and